varicella-zoster virus infection mRNA vaccine (Walvax Biotechnology/Suzhou Abogen Biosciences)

N/A

Report date: 2025/12/12 17:32:35

Base Information

Drug Namevaricella-zoster virus infection mRNA vaccine (Walvax Biotechnology/Suzhou Abogen Biosciences)
Drug Alias Nameherpes zoster vaccine (Walvax Biotechnology/Suzhou Abogen Biosciences)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanMacauHong Kong +[4] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAbogen Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWalvax Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A